HomeIDRSF • OTCMKTS
Idorsia Ltd
$0.87
Nov 27, 8:10:00 PM GMT-5 · USD · OTCMKTS · Disclaimer
StockUS listed security
Previous close
$0.84
Day range
$0.87 - $0.87
Year range
$0.81 - $2.88
Market cap
167.68M CHF
Avg Volume
506.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
In the news
Financials
Income Statement
Revenue
Net income
(CHF)Sep 2024Y/Y change
Revenue
26.20M-67.21%
Operating expense
63.99M-6.32%
Net income
-101.04M-145.10%
Net profit margin
-385.61-237.55%
Earnings per share
EBITDA
-83.92M-83.27%
Effective tax rate
-0.17%
Total assets
Total liabilities
(CHF)Sep 2024Y/Y change
Cash and short-term investments
103.15M-61.24%
Total assets
512.84M-21.48%
Total liabilities
1.64B10.43%
Total equity
-1.13B
Shares outstanding
188.31M
Price to book
-0.14
Return on assets
-37.84%
Return on capital
-125.83%
Net change in cash
(CHF)Sep 2024Y/Y change
Net income
-101.04M-145.10%
Cash from operations
-143.71M-88.55%
Cash from investing
-1.23M-100.46%
Cash from financing
0.00100.00%
Net change in cash
-92.14M-190.50%
Free cash flow
-83.97M-2,363.30%
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Employees
938
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
Search
Clear search
Close search
Google apps
Main menu